42 results on '"Isgrò A"'
Search Results
2. Thombosis, major bleeding, and survival in COVID-19 supported by veno-venous extracorporeal membrane oxygenation in the first vs second wave: a multicenter observational study in the United Kingdom
3. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies
4. Effects of Action Observation Therapy in Patients Recovering From Total Hip Arthroplasty Arthroplasty: A Prospective Clinical Trial
5. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: A retrospective study
6. Qualitative and quantitative differences of adipose-derived stromal cells from superficial and deep subcutaneous lipoaspirates: a matter of fat
7. Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach
8. Microsurgical Testis-sparing Surgery in Small Testicular Masses: Seven Years Retrospective Management and Results
9. Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring
10. Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia
11. Immunohematologic Reconstitution in Pediatric Patients after T Cell-Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia
12. Late-Onset Hemorrhagic Cystitis in Children after Hematopoietic Stem Cell Transplantation for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir
13. Continuous Monitoring of Central Venous Oxygen Saturation (Pediasat) in Pediatric Patients Undergoing Cardiac Surgery: A Validation Study of a New Technology
14. SVD-matching using SIFT features
15. The antithrombin III–saving effect of reduced systemic heparinization and heparin-coated circuits
16. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients
17. The Right Ventricle in COVID-19 Lung Injury: Proposed Mechanisms, Management, and Research Gaps
18. Comparison of two different anesthesia regimens in patients undergoing aortocoronary bypass grafting surgery: Sufentanil-midazolam versus remifentanil-propofol
19. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass
20. A Case of Fatal Bleeding Following Emergency Surgery on an Ascending Aorta Intramural Hematoma in a Patient Taking Dabigatran
21. Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies
22. Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors
23. Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft
24. PCN263 - Role of Clinical Pharmacist in Optimizing Reimbursement Originating from Performance-Based Risk-Sharing Arrangements: The Experience of the University Hospital “G. Martino” from Messina, Italy
25. Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia
26. Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients
27. Wound Care of Pretibial Thin-skin Lacerations With the Combined Use of Sterile Adhesive Strips and Sutures
28. Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach
29. Cyclophosphamide (CYC) exposure in pediatric patients with systemic lupus erythematosus (pSLE) is associated with reduced serum anti-mullerian hormone (AMH) levels
30. Prefibrotic Myelofibrosis (PreMF) Belongs to a Continuum of Epidemiological, Clinical and Histological Characteristics Featuring Primary Myelofibrosis (PMF)
31. A Novel Treatment Protocol Successfully Prevented Graft Rejection and Improved Disease-Free Survival in Class 3 Children with Thalassemia
32. Thiotepa in the Conditioning Regimen Decreases Rejection after HLA Identical Allogeneic Marrow Transplantation in Children with Beta Thalassemia Major Aged Less Then 4 Years
33. Donor's NK Cells May Influence the Engraftment in Pediatrics Patients after T-Cell Depleted Haploidentical Stem Cell Transplant for Thalassemia
34. Immunological Evaluation after Haematopoietic Stem Cell Transplantation for B–Thalassemia Major
35. Bone Marrow Iron Concentration as a Marker of Iron Accumulation and Marrow Expansion in Patients with Beta Thalassemia Major.
36. Clinical Outcomes and Pharmacokinetics of Targeted Intravenous Busulfan in Children Receiving Stem Cell Transplantation for Thalassemia.
37. High Engraftment Rate after Second Stem Cell Transplantation for Thalassemia: A Prospective Study.
38. Early T Cell Recovery of Thymus-Derived Naive T Cells and NK Cells in Pediatrics Patients after T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia.
39. Immuno Haematological Reconstitution after T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia.
40. Su.2. Mesenchymal Stem Cells Derived from Human Periodontal Ligament Efficiently Support Hematopoietic Precursors and Produce High Amounts of Il-7
41. Critical hematocrit during extracorporeal circulation
42. Pain management in cardiac surgery patients: Comparison between standard therapy and patient-controlled analgesia regimen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.